Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
New Research Supports Proposed Reform of Medicare’s Competitive Bidding Program for DMEPOS
The Pacific Research Institute study underscores the need to reform Medicare’s current bidding and payment processes - July 27, 2018 - CQRC
ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO
ALPCO and InSphero Partner to Offer a Complete Solution to Assess Beta-cell Function in Islet Microtissue Culture Models
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO
Perio Health Professionals Bolsters Leadership with Floyd Griffith as Chief Innovations Officer
Perio Health Professionals (PHP) is pleased to announce the addition of Floyd Griffith as its Chief Innovations Officer, a newly created position at the company. Mr. Griffith will lead the day-to-day operations of the surgical center and spearhead its strategic priorities. PHP is a locally... - July 24, 2018 - Perio Health Professionals
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
ALPCO Releases STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA to Accurately Quantify Fasted Levels
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25... - July 17, 2018 - ALPCO
MITA Applauds New Research Showing Effectiveness of High Intensity Focused Ultrasound in Treating Prostate Cancer
Five-Year, multicenter study of UK cancer prostate patients reveals the clinical benefits and reduced side effects of HIFU - July 09, 2018 - Medical Imaging and Technology Alliance
Presbyterian/St. Luke’s Joins the Fight Against Sarcoma by Sponsoring Upcoming “Rock the Cause” Event
The Institute for Limb Preservation (ILP), in partnership with Sarah Cannon Cancer Institute (Sarah Cannon) at Presbyterian/St. Luke’s Medical Center (P/SL), is proud to sponsor “Rock the Cause Sarcoma Awareness,” an event geared to raise funds and awareness for the Sarcoma... - July 04, 2018 - Presbyterian/St. Luke's Medical Center
HCA/HealthONE's The Medical Center of Aurora: Pioneering Spine Surgery
The Medical Center of Aurora (TMCA) is among the first hospitals in Colorado to begin using a new bone graft tool to achieve better patient outcomes in spinal fusions. TMCA spine surgeon, Stephen Pehler, MD, is conducting minimally invasive spinal fusion procedures using the new device and in the process increasing patient success rates for spinal fusions from the national average of 75% to 92%. - July 03, 2018 - The Medical Center of Aurora
Presbyterian/St. Luke’s Medical Center Performs Cutting Edge Minimally Invasive Bone Cancer Surgery
Presbyterian/St. Luke’s Medical Center (P/SL) is pleased to have performed the 3rd percutaneous (minimally invasive) acetabular reconstruction in the U.S. to treat metastatic bone cancer of the pelvis. There are approximately 250,000 people in the U.S. with metastatic bone cancer (cancer... - June 28, 2018 - Presbyterian/St. Luke's Medical Center
Perimeter Medical Imaging Inc Appoints Charles S. Carignan, MD as New CEO
Perimeter Medical Imaging Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the appointment of Charles S. Carignan, MD as CEO. Dr. Carignan has more than 20 years of experience in key leadership positions spanning the medical imaging,... - June 26, 2018 - Perimeter Medical Imaging Inc
Dr. Alan Michelson to Advise LightIntegra Technology
Platelet expert, Dr. Alan Michelson has begun consulting as a Scientific Advisor to LightIntegra Technology, the creators of the ThromboLUX System. - June 26, 2018 - LightIntegra Technology
IVI Announces Next Open-Source Value Assessment Platform Will Focus on Lung Cancer
Collaboration with LUNGevity Will Develop Patient-Centric Models to Assess Value in Innovative Lung Cancer Therapies - June 20, 2018 - Innovation and Value Initiative
Speakers Inspire Audience at Regional Conference on Necrotizing Enterocolitis
The inaugural Speaking of NEC: Unplugged event, a one-day regional conference focused on identifying practical solutions for reducing the devastating effects of Necrotizing Enterocolitis (NEC) on premature infants and their families took place on June 11, 2018 at the Courtyard by Marriott in... - June 20, 2018 - The Morgan Leary Vaughan Fund, Inc.
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO
APDM Wearable Technologies Awarded NIH Funding to Commercialize Novel Biofeedback System
APDM Wearable Technologies has been awarded a National Institute on Aging SBIR Phase II grant totaling $1.6 million to commercialize a real-time biofeedback system. With this funding, APDM will develop the industry's first over-ground gait biofeedback rehabilitation system utilizing both visual and... - June 19, 2018 - APDM Wearable Technologies
Vesalio Reports Expansion of Commercial Distribution, Additional Published Data on the NeVa™ System for Treating Stroke Patients
Vesalio announces it has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System. All channel partners have been trained on the unique features of the NeVa platform and technique that is optimized for capturing... - June 18, 2018 - Vesalio
BÜHLMANN Laboratories AG Receives FDA Clearance for Its fCAL® ELISA Calprotectin Test
BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. - June 14, 2018 - BUHLMANN Diagnostics Corp
Autism Service Dog to Help 17-Year-Old Girl in Madison, CT
Maeve, a 17-year old girl living in Madison, Connecticut, received a very special delivery of an Autism Service Dog from Service Dogs by Warren Retrievers to help better communicate her needs on the spectrum. - June 12, 2018 - Service Dogs by SDWR
Leona W. Ayers, M.D. Acknowledged as a Most Influential Business Professional by Strathmore's Who's Who Worldwide Publication
Leona W. Ayers, M.D. of Dublin, Ohio has been acknowledged as a Most Influential Business Professional for 2018 by Strathmore’s Who’s Who Worldwide for her outstanding achievements and high level of success for over 40 years in the fields of education and medical research. About Leona... - June 02, 2018 - Strathmore Worldwide
CQRC Warns OIG Report on Competitive Bidding Fails to Accurately Assess Impact of Program on Beneficiary Access
Competitive Bidding Program Documented as Putting Millions of Patients at Risk by Limiting Patient Access and Driving Up Medicare Spending. - May 29, 2018 - CQRC
Avior Nutritionals: Gaining Synergy by Combining High-Dose Biotin and NAD+ for Neurological Health
In a recently completed 180-day pilot study using Myetin, participants reported a 48% improvement in pain and a 15% improvement in fatigue while taking the combination of High Dose D-Biotin and nicotinamide adenine dinucleotide (also called NAD+). Study participants recorded their quality of life in a number of categories using an online tracker over the 180-day trial period. - May 29, 2018 - Avior Nutritionals- NADIA Skin
Pediatrician Accreditation Pilot to Improve HPV Vaccination Rates
Research shows the HPV vaccine prevents cancer, and preteens can be protected by strong provider recommendation. Enrollment is now open for pediatricians in Illinois and Wisconsin for an accredited quality improvement project to increase vaccination rates, and participants can register on an individual basis or by practice. - May 24, 2018 - Wisconsin Chapter, American Academy of Pediatrics
Book on New Way of Doing Medicine Could Save Lives
Adult Stem Cell Released Molecules is a new book on therapeutic development and medicine, by California author Dr. Greg Maguire, Ph.D., that could save lives and restore health. Dr. Greg Maguire's book offers a radically new approach to the standard means of developing therapeutics through the use of the molecules that stem cells release, emphasizing that the molecules act in the organisms through their collective actions within and between all levels of the system, often not at the genome. - May 23, 2018 - BioRegenerative Sciences, Inc.
New Report: More Than 60 Percent of Patients Seeking Proton Therapy Are Initially Denied by Nation's Insurers
Alliance for Proton Therapy Access launches grassroots campaign calling for state insurance commissioners to fix broken insurance process. - May 17, 2018 - Alliance for Proton Therapy Access
Mercodia Launches Unique Quality System
The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB
Manufacturing the Future of Healthcare at 3D Printing for Healthcare Summit
Roosevelt Strategic Council is pleased to announce the 3D Printing for Healthcare Summit, occurring July 24-25, 2018 at Spire Events Center, Washington, DC. The increased commercial utilization of 3D printing technologies has dramatically altered conventional manufacturing processes across... - May 16, 2018 - Defense Strategies Institute
$3.7M Research Grant Awarded to Artificial Intelligence Project for Medical Imaging
University of Waterloo’s Kimia receives $3.7M for its AI project for digital pathology. - May 16, 2018 - Kimia Lab, University of Waterloo
P3 Healthcare Solutions Offers Free Demo of Its Medical Billing Service
P3 Healthcare Solution Offers Free Demo of its value-added medical billing service to the providers. Get to know more about a provider-focused medical billing service. - May 12, 2018 - P3 Healthcare Solutions
Charles Laverty’s Mission to Reduce Heart Surgery
Heart disease kills 17M people every year and is the top global killer almost everywhere in the world. Overburdened healthcare systems are struggling to keep up with the growth, especially as populations age, economies develop and people adopt "western" style diets and lifestyles. Charles Laverty is on a mission to attack a major area of this global pandemic, open heart surgery. By adopting new technologies it may be possible to reduce surgery. - May 10, 2018 - Advanced Bifurcation Systems
American Association on Health and Disability (AAHD) Joins NIH in Launching the All of Us Research Program to Advance Precision Medicine
On May 6, the National Institutes of Health (NIH) will open national enrollment for the All of Us Research Program - a momentous effort to advance individualized prevention, treatment and care for people of all backgrounds, including people with disabilities. - May 04, 2018 - American Association on Health and Disability
EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines
EpicentRx, a San Diego biotechnology company developing a next-generation immunotherapy platform of viruses that infect and kill cancer cells for the treatment of several tumor types, has developed the first ever series of oncolytic viruses tailored to tumors of individual patients. The first... - May 03, 2018 - EpicentRx, INC
Helen V. Ratajczak Edmond Has Recently Been Recognized by Strathmore’s Who’s Who
Helen V. Ratajczak Edmond, of Danbury, Connecticut, has recently been recognized as a Strathmore’s Who’s Who Professional of the Year for her outstanding contributions and achievements in field of Healthcare Therapy. - May 02, 2018 - Strathmore Who's Who
From Homeless to Top Student Researcher at Southern Utah University
From living on the streets of Los Angeles to graduating top of his class, Donald Long, a first-generation student, says Southern Utah University gave him a second chance. After graduating from high school in New Jersey, Long joined the Air Force branch of the military from 2000 to 2004. There, he... - April 25, 2018 - Southern Utah University
AloeVeritas Along with PainSmarts and the GPOSO, Announce Initiation of Phase I Observational Study Evaluating AloeMD
AloeVeritas along with PainSmarts and GPOSO (Global Professional Observational Study Organization), Announce Initiation of Phase I Observational Study Evaluating AloeMD for the relief of pain without Opioids, Steroids, and NSAIDs. - April 20, 2018 - AloeMD
Proton Therapy Advocates Underscore Need for Fair and Timely Access to Treatment for Cancer Patients During Esophageal Cancer Awareness Month
Data show proton therapy associated with fewer post-operative complications and shorter hospital stays for patients living with esophageal cancer. - April 18, 2018 - Alliance for Proton Therapy Access
New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company
Stratus Interoperable™ Announces “Letter of Intent” (LOI) with UPSA ACO
Stratus Interoperable and UPSA ACO to customize StratusLink data management platform for the ACO market. - April 17, 2018 - Stratus Interoperable
Assisted Reproductive Technology / In Vitro Fertilization (ART / IVF) Success is Lower in Young Women; Its Decline Begins Earlier Than Thought, Occurs at Increasing Rates
Previously, it was assumed that ART/IVF success in women using their fresh embryos remains stable until mid-30s before it begins to decline. But a new study of CDC data with almost half a million cycles disproves this and shows success is lower also in very young women, up to age 28, and declining thereafter. Age-driven decline begins earlier than at previously thought mid-30s and occurs at increasing rates. Infertile women older than 30 should not delay ART/IVF treatment, if it is their option. - April 13, 2018 - Stats of the ART
Brussels, May 23: Seven Large EU-Funded Projects Join Forces at epiXchange 2018 to Pave the Way for Future Epilepsy Research
Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects have joined forces. - April 12, 2018 - ARTTIC S.A.S
Healthcare Tech Outlook Editorial Board Recognizes Stratus Interoperable as "Top 10 Population Health Management Solutions Provider 2018"
StratusLink - AI ready Healthcare data management and business intelligence platform chosen as Top Ten Population Health Management Solutions 2018 - April 09, 2018 - Stratus Interoperable
Leona W. Ayers, M.D. Honored as a Woman of Distinction by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)
Leona W. Ayers, M.D. of Dublin, Ohio has been honored as a Woman of Distinction for the second quarter of 2018 by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized) for her outstanding achievements and high level of success in the field of education. Each quarter P.O.W.E.R. - April 06, 2018 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
XECAN Integrates Palm, Facial Recognition and RFID Identification Devices to MOSAIQ via Its Software, Bringing Improvements to Delivery of Care
XECAN today announced its compatibility with Elekta’s MOSAIQ Patient Verification and Patient Queuing Modules to bring biometric/RFID workflow improvement solutions to Elekta’s MOSAIQ. Using smart ID technology, XECAN improves clinical workflow and patient satisfaction through the use... - April 03, 2018 - Xecan Smart Clinic
Naghmana Bajwa, M.D. Recognized as a VIP Member by Strathmore's Who's Who Worldwide Publication
Naghmana Bajwa, M.D. of Long Grove, Illinois has been recognized as a VIP Member for 2018 by Strathmore’s Who’s Who Worldwide for her outstanding contributions and achievements in the field of research & development. About Naghmana Bajwa, M.D. Dr. Naghmana Bajwa has almost 20 years... - March 28, 2018 - Strathmore Worldwide
PuRxCell Names Medical Director for the Philippine Islands
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products. Robert J. Colucci CEO of PuRxCell, LLC, a Florida based company, announced today that PuRxCell, has named Dr. Jeimylo C. de Castro as its Medical Director for the Philippine Islands and parts of Asia. “Doctor de Castro... - March 23, 2018 - PuRxCell
Vesalio Reports Positive Results in Early NeVa™ Human Thrombectomy Procedures and Recently Published Pre-Clinical Data
Vesalio announces it has completed European enrollment of the first twenty-five human cases in a post-market registry of the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke. With procedures performed at six centers in four countries to date, early results demonstrate... - March 22, 2018 - Vesalio
A Unique Blended Learning Program in Aesthetic Dentistry That Gives a Level 7 Post Graduate Certificate from the UK
Academy of Dental Excellence (https://dentalexcellence.academy) announces a unique blended learning Programme in Aesthetic Dentistry that gives a Level 7 Post Graduate Certificate from the UK. Dentists with busy schedules now have an opportunity to enhance their dental knowledge and skills, at... - March 20, 2018 - Academy of Dental Excellence
Chromista Algae Oil Recognized Best CBD Oil Emulsifier
Source-Omega today discloses astounding commercial R&D results with pure Chromista water extracted algae oil. With first and only claims such as the first water extracted algae oil, the first single ingredient 100% algae oil (Schizochytrium sp.), the first 50% DHA oil standard, Source-Omega... - March 15, 2018 - Source-Omega
ClinSearch Announces Transition in Leadership Team Welcomes Mark M. McKenzie, M.D. as Medical Director
ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the... - March 10, 2018 - Wake Research Associates
2018 Hope APFED/AAAAI Pilot Grant Award Recipient Announced
Funded study to look at effects of proton pump inhibitor treatment on genes associated with eosinophilic esophagitis. - March 09, 2018 - APFED